JPY 4236.0
(0.09%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 30.24 Billion JPY | -20.18% |
2022 | 37.88 Billion JPY | -6.99% |
2021 | 40.73 Billion JPY | -7.21% |
2020 | 43.9 Billion JPY | -1.88% |
2019 | 44.74 Billion JPY | 18.2% |
2018 | 37.85 Billion JPY | 39.36% |
2017 | 27.16 Billion JPY | -2.84% |
2016 | 27.95 Billion JPY | -19.75% |
2015 | 34.83 Billion JPY | -12.28% |
2014 | 39.71 Billion JPY | 14.44% |
2013 | 34.7 Billion JPY | 48.36% |
2012 | 23.39 Billion JPY | -28.47% |
2011 | 32.7 Billion JPY | -12.49% |
2010 | 37.37 Billion JPY | 1.7% |
2009 | 36.75 Billion JPY | 124.06% |
2008 | 16.4 Billion JPY | -3.12% |
2007 | 16.93 Billion JPY | 12.88% |
2006 | 14.99 Billion JPY | -29.43% |
2005 | 21.25 Billion JPY | -6.31% |
2004 | 22.68 Billion JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 28.6 Billion JPY | -5.41% |
2023 Q2 | 37.02 Billion JPY | -1.78% |
2023 Q3 | 36.34 Billion JPY | -1.86% |
2023 Q4 | 30.24 Billion JPY | -16.78% |
2023 Q1 | 37.69 Billion JPY | -0.5% |
2023 FY | 30.24 Billion JPY | -20.18% |
2022 Q2 | 37.64 Billion JPY | -2.18% |
2022 FY | 37.88 Billion JPY | -6.99% |
2022 Q4 | 37.88 Billion JPY | 2.47% |
2022 Q1 | 38.48 Billion JPY | -5.53% |
2022 Q3 | 36.97 Billion JPY | -1.78% |
2021 Q3 | 39.96 Billion JPY | -1.63% |
2021 Q1 | 41.24 Billion JPY | -6.04% |
2021 Q2 | 40.63 Billion JPY | -1.5% |
2021 FY | 40.73 Billion JPY | -7.21% |
2021 Q4 | 40.73 Billion JPY | 1.92% |
2020 Q2 | 42.93 Billion JPY | -0.93% |
2020 Q1 | 43.34 Billion JPY | -3.13% |
2020 FY | 43.9 Billion JPY | -1.88% |
2020 Q4 | 43.9 Billion JPY | 4.64% |
2020 Q3 | 41.95 Billion JPY | -2.3% |
2019 Q4 | 44.74 Billion JPY | 71.36% |
2019 FY | 44.74 Billion JPY | 18.2% |
2019 Q3 | 26.11 Billion JPY | -11.36% |
2019 Q1 | 34.16 Billion JPY | -9.73% |
2019 Q2 | 29.45 Billion JPY | -13.79% |
2018 Q3 | 39.78 Billion JPY | -0.67% |
2018 Q4 | 37.85 Billion JPY | -4.84% |
2018 Q2 | 40.05 Billion JPY | -3.98% |
2018 Q1 | 41.71 Billion JPY | 53.57% |
2018 FY | 37.85 Billion JPY | 39.36% |
2017 Q3 | 24.5 Billion JPY | -1.36% |
2017 Q2 | 24.84 Billion JPY | 20.5% |
2017 Q1 | 20.61 Billion JPY | -26.26% |
2017 FY | 27.16 Billion JPY | -2.84% |
2017 Q4 | 27.16 Billion JPY | 10.84% |
2016 Q4 | 27.95 Billion JPY | 21.11% |
2016 Q3 | 23.08 Billion JPY | -4.08% |
2016 FY | 27.95 Billion JPY | -19.75% |
2016 Q2 | 24.06 Billion JPY | -9.45% |
2016 Q1 | 26.57 Billion JPY | -23.72% |
2015 FY | 34.83 Billion JPY | -12.28% |
2015 Q1 | 27.78 Billion JPY | -30.05% |
2015 Q2 | 28.37 Billion JPY | 2.14% |
2015 Q3 | 26.2 Billion JPY | -7.64% |
2015 Q4 | 34.83 Billion JPY | 32.93% |
2014 Q4 | 39.71 Billion JPY | 23.23% |
2014 FY | 39.71 Billion JPY | 14.44% |
2014 Q1 | 19.17 Billion JPY | -44.74% |
2014 Q3 | 32.23 Billion JPY | 60.77% |
2014 Q2 | 20.04 Billion JPY | 4.53% |
2013 FY | 34.7 Billion JPY | 48.36% |
2013 Q2 | 28.35 Billion JPY | 15.88% |
2013 Q1 | 24.46 Billion JPY | 4.6% |
2013 Q3 | 23.41 Billion JPY | -17.43% |
2013 Q4 | 34.7 Billion JPY | 48.23% |
2012 Q3 | 23.24 Billion JPY | 1.03% |
2012 Q1 | 23.9 Billion JPY | -26.92% |
2012 Q2 | 23 Billion JPY | -3.74% |
2012 FY | 23.39 Billion JPY | -28.47% |
2012 Q4 | 23.39 Billion JPY | 0.64% |
2011 Q4 | 32.7 Billion JPY | 5.11% |
2011 Q3 | 31.11 Billion JPY | -15.86% |
2011 FY | 32.7 Billion JPY | -12.49% |
2011 Q2 | 36.98 Billion JPY | 9.2% |
2011 Q1 | 33.86 Billion JPY | -9.39% |
2010 Q3 | 32.03 Billion JPY | -3.58% |
2010 Q1 | 34.82 Billion JPY | -5.23% |
2010 Q2 | 33.22 Billion JPY | -4.6% |
2010 FY | 37.37 Billion JPY | 1.7% |
2010 Q4 | 37.37 Billion JPY | 16.67% |
2009 Q2 | 33.73 Billion JPY | 0.0% |
2009 FY | 36.75 Billion JPY | 124.06% |
2009 Q3 | 27.18 Billion JPY | -19.42% |
2009 Q4 | 36.75 Billion JPY | 35.21% |
2008 Q4 | 16.4 Billion JPY | 6.84% |
2008 FY | 16.4 Billion JPY | -3.12% |
2008 Q3 | 15.35 Billion JPY | 0.0% |
2007 FY | 16.93 Billion JPY | 12.88% |
2006 FY | 14.99 Billion JPY | -29.43% |
2005 FY | 21.25 Billion JPY | -6.31% |
2004 FY | 22.68 Billion JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 16.89 Billion JPY | -79.054% |
Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.376% |
Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 92.78% |
Shionogi & Co., Ltd. | 11.62 Billion JPY | -160.275% |
Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -29984.851% |
Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -953.064% |
Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -685.558% |
Eisai Co., Ltd. | 206.74 Billion JPY | 85.371% |
Morishita Jintan Co., Ltd. | 425 Million JPY | -7016.235% |
Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -1340.19% |
Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -8096.206% |
Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | -137.73% |
Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | -78.105% |
Tsumura & Co. | 79.69 Billion JPY | 62.048% |
Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -1651.245% |
Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -12295.082% |
Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 85.054% |
Fuji Pharma Co., Ltd. | 28.94 Billion JPY | -4.477% |
Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | 36.443% |
KYORIN Holdings, Inc. | 20.94 Billion JPY | -44.39% |
Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -694.014% |
Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -246.875% |
SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
MedRx Co., Ltd | - JPY | -Infinity% |
Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
Solasia Pharma K.K. | 60 Million JPY | -50306.667% |
Modalis Therapeutics Corporation | 412.5 Million JPY | -7231.879% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -218.861% |
Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 63.513% |
Cyfuse Biomedical K.K. | 913 Million JPY | -3212.596% |
Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -970.475% |